BACKGROUND: Prostate cancer (PC) is generally believed to have a strong inherited component, but the search for susceptibility genes has been hindered by the effects of genetic heterogeneity. The recently developed sumLINK and sumLOD statistics are powerful tools for linkage analysis in the presence of heterogeneity. METHODS: We performed a secondary analysis of 1,233 PC pedigrees from the International Consortium for Prostate Cancer Genetics (ICPCG) using two novel statistics, the sumLINK and sumLOD. For both statistics, dominant and recessive genetic models were considered. False discovery rate (FDR) analysis was conducted to assess the effects of multiple testing. RESULTS: Our analysis identified significant linkage evidence at chromosome 22q12, confirming previous findings by the initial conventional analyses of the same ICPCG data. Twelve other regions were identified with genome-wide suggestive evidence for linkage. Seven regions (1q23, 5q11, 5q35, 6p21, 8q12, 11q13, 20p11-q11) are near loci previously identified in the initial ICPCG pooled data analysis or the subset of aggressive PC pedigrees. Three other regions (1p12, 8p23, 19q13) confirm loci reported by others, and two (2p24, 6q27) are novel susceptibility loci. FDR testing indicates that over 70% of these results are likely true positive findings. Statistical recombinant mapping narrowed regions to an average of 9 cM. CONCLUSIONS: Our results represent genomic regions with the greatest consistency of positive linkage evidence across a very large collection of high-risk PC pedigrees using new statistical tests that deal powerfully with heterogeneity. These regions are excellent candidates for further study to identify PC predisposition genes.
BACKGROUND:Prostate cancer (PC) is generally believed to have a strong inherited component, but the search for susceptibility genes has been hindered by the effects of genetic heterogeneity. The recently developed sumLINK and sumLOD statistics are powerful tools for linkage analysis in the presence of heterogeneity. METHODS: We performed a secondary analysis of 1,233 PC pedigrees from the International Consortium for Prostate Cancer Genetics (ICPCG) using two novel statistics, the sumLINK and sumLOD. For both statistics, dominant and recessive genetic models were considered. False discovery rate (FDR) analysis was conducted to assess the effects of multiple testing. RESULTS: Our analysis identified significant linkage evidence at chromosome 22q12, confirming previous findings by the initial conventional analyses of the same ICPCG data. Twelve other regions were identified with genome-wide suggestive evidence for linkage. Seven regions (1q23, 5q11, 5q35, 6p21, 8q12, 11q13, 20p11-q11) are near loci previously identified in the initial ICPCG pooled data analysis or the subset of aggressive PC pedigrees. Three other regions (1p12, 8p23, 19q13) confirm loci reported by others, and two (2p24, 6q27) are novel susceptibility loci. FDR testing indicates that over 70% of these results are likely true positive findings. Statistical recombinant mapping narrowed regions to an average of 9 cM. CONCLUSIONS: Our results represent genomic regions with the greatest consistency of positive linkage evidence across a very large collection of high-risk PC pedigrees using new statistical tests that deal powerfully with heterogeneity. These regions are excellent candidates for further study to identify PC predisposition genes.
Authors: Bao-Li Chang; Wennuan Liu; Jishan Sun; Latchezar Dimitrov; Tao Li; Aubrey R Turner; Siqun L Zheng; William B Isaacs; Jianfeng Xu Journal: Cancer Res Date: 2007-05-01 Impact factor: 12.701
Authors: Maya Ghoussaini; Honglin Song; Thibaud Koessler; Ali Amin Al Olama; Zsofia Kote-Jarai; Kristy E Driver; Karen A Pooley; Susan J Ramus; Susanne Krüger Kjaer; Estrid Hogdall; Richard A DiCioccio; Alice S Whittemore; Simon A Gayther; Graham G Giles; Michelle Guy; Stephen M Edwards; Jonathan Morrison; Jenny L Donovan; Freddie C Hamdy; David P Dearnaley; Audrey T Ardern-Jones; Amanda L Hall; Lynne T O'Brien; Beatrice N Gehr-Swain; Rosemary A Wilkinson; Paul M Brown; John L Hopper; David E Neal; Paul D P Pharoah; Bruce A J Ponder; Rosalind A Eeles; Douglas F Easton; Alison M Dunning Journal: J Natl Cancer Inst Date: 2008-06-24 Impact factor: 13.506
Authors: Wennuan Liu; Jishan Sun; Ge Li; Yi Zhu; Scott Zhang; Seong-Tae Kim; Jielin Sun; Fredrik Wiklund; Kathleen Wiley; Sarah D Isaacs; Pär Stattin; Jianfeng Xu; David Duggan; John D Carpten; William B Isaacs; Henrik Grönberg; S Lilly Zheng; Bao-Li Chang Journal: Cancer Res Date: 2009-03-03 Impact factor: 12.701
Authors: Nicola J Camp; Lisa A Cannon-Albright; James M Farnham; Agnes B Baffoe-Bonnie; Asha George; Isaac Powell; Joan E Bailey-Wilson; John D Carpten; Graham G Giles; John L Hopper; Gianluca Severi; Dallas R English; William D Foulkes; Lovise Maehle; Pal Moller; Ros Eeles; Douglas Easton; Michael D Badzioch; Alice S Whittemore; Ingrid Oakley-Girvan; Chih-Lin Hsieh; Latchezar Dimitrov; Jianfeng Xu; Janet L Stanford; Bo Johanneson; Kerry Deutsch; Laura McIntosh; Elaine A Ostrander; Kathleen E Wiley; Sarah D Isaacs; Patrick C Walsh; Stephen N Thibodeau; Shannon K McDonnell; Scott Hebbring; Daniel J Schaid; Ethan M Lange; Kathleen A Cooney; Teuvo L J Tammela; Johanna Schleutker; Thomas Paiss; Christiane Maier; Henrik Grönberg; Fredrik Wiklund; Monica Emanuelsson; William B Isaacs Journal: Hum Mol Genet Date: 2007-05-03 Impact factor: 6.150
Authors: Daniel J Schaid; Shannon K McDonnell; Katherine E Zarfas; Julie M Cunningham; Scott Hebbring; Stephen N Thibodeau; Rosalind A Eeles; Douglas F Easton; William D Foulkes; Jacques Simard; Graham G Giles; John L Hopper; Lovise Mahle; Pal Moller; Michael Badzioch; D Timothy Bishop; Chris Evans; Steve Edwards; Julia Meitz; Sarah Bullock; Questa Hope; Michelle Guy; Chih-lin Hsieh; Jerry Halpern; Raymond R Balise; Ingrid Oakley-Girvan; Alice S Whittemore; Jianfeng Xu; Latchezar Dimitrov; Bao-Li Chang; Tamara S Adams; Aubrey R Turner; Deborah A Meyers; Danielle M Friedrichsen; Kerry Deutsch; Suzanne Kolb; Marta Janer; Leroy Hood; Elaine A Ostrander; Janet L Stanford; Charles M Ewing; Marta Gielzak; Sarah D Isaacs; Patrick C Walsh; Kathleen E Wiley; William B Isaacs; Ethan M Lange; Lindsey A Ho; Jennifer L Beebe-Dimmer; David P Wood; Kathleen A Cooney; Daniela Seminara; Tarja Ikonen; Agnes Baffoe-Bonnie; Henna Fredriksson; Mika P Matikainen; Teuvo L J Tammela; Joan Bailey-Wilson; Johanna Schleutker; Christiane Maier; Kathleen Herkommer; Josef J Hoegel; Walther Vogel; Thomas Paiss; Fredrik Wiklund; Monica Emanuelsson; Elisabeth Stenman; Björn-Anders Jonsson; Henrik Grönberg; Nicola J Camp; James Farnham; Lisa A Cannon-Albright; William J Catalona; Brian K Suarez; Kimberly A Roehl Journal: Hum Genet Date: 2006-08-25 Impact factor: 4.132
Authors: Cheryl D Cropp; Claire L Simpson; Tiina Wahlfors; Nati Ha; Asha George; MaryPat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Tiffany A Green; Teuvo L J Tammela; Joan Bailey-Wilson; Johanna Schleutker Journal: Int J Cancer Date: 2011-04-20 Impact factor: 7.396
Authors: Bradford D Wilson; Luisel J Ricks-Santi; Tshela E Mason; Muneer Abbas; Rick A Kittles; Georgia M Dunston; Yasmine M Kanaan Journal: Cancer Genomics Proteomics Date: 2018 May-Jun Impact factor: 4.069
Authors: Daniel J Schaid; Shannon K McDonnell; Liesel M FitzGerald; Lissa DeRycke; Zachary Fogarty; Graham G Giles; Robert J MacInnis; Melissa C Southey; Tu Nguyen-Dumont; Geraldine Cancel-Tassin; Oliver Cussenot; Alice S Whittemore; Weiva Sieh; Nilah Monnier Ioannidis; Chih-Lin Hsieh; Janet L Stanford; Johanna Schleutker; Cheryl D Cropp; John Carpten; Josef Hoegel; Rosalind Eeles; Zsofia Kote-Jarai; Michael J Ackerman; Christopher J Klein; Diptasri Mandal; Kathleen A Cooney; Joan E Bailey-Wilson; Brian Helfand; William J Catalona; Fredrick Wiklund; Shaun Riska; Saurabh Bahetti; Melissa C Larson; Lisa Cannon Albright; Craig Teerlink; Jianfeng Xu; William Isaacs; Elaine A Ostrander; Stephen N Thibodeau Journal: Eur Urol Date: 2020-08-14 Impact factor: 20.096